Hidden Ingredient in Ozempic and Wegovy Tablets Raises New Gut Health Questions
Researchers at Adelaide University conducted the first in‑vivo study of salcaprozate sodium (SNAC), the absorption enhancer used in oral semaglutide tablets such as Ozempic and Wegovy. Over a 21‑day period in rats, repeated SNAC exposure reduced fibre‑degrading gut bacteria, lowered short‑chain fatty acids, raised inflammatory markers, increased liver weight and shrank the cecum, while also decreasing a brain‑derived protein linked to cognition. The results suggest SNAC may exert biological effects beyond drug delivery, though human relevance remains unproven. As oral obesity treatments gain market share, daily SNAC intake could rise substantially.
Scientists Discover Diet that Tricks the Body Into Burning Fat without Exercise
Scientists at the University of Southern Denmark discovered that restricting dietary methionine and cysteine triggers thermogenesis comparable to chronic cold exposure, leading to significant weight loss in mice. Over a week, mice on the amino‑acid‑restricted diet burned 20% more calories...
American Heart Association Warns 60% of US Women Will Have Cardiovascular Disease by 2050
The American Heart Association’s new scientific statement projects that nearly six in ten U.S. women will live with cardiovascular disease (CVD) by 2050, driven by rising hypertension, obesity, and diabetes. By 2050, high blood pressure could affect almost 60% of...
Study Finds Vegetarians over 80 Less Likely to Reach 100
A longitudinal study of more than 5,000 Chinese adults aged 80 and older found that non‑meat eaters were less likely to become centenarians than meat eaters. The disparity was confined to participants who were underweight, while those of normal weight...
Just Two Days of Oatmeal Cut Bad Cholesterol by 10%
A University of Bonn randomized trial published in Nature Communications found that a two‑day, calorie‑restricted diet consisting of 300 g of oatmeal per day reduced LDL cholesterol by about 10 percent in participants with metabolic syndrome. The oat‑rich group also lost roughly...